Parma Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Parma
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Parma News
Pharma major Dr. Reddy’s to produce and market drug for gonorrhoea granted approval by U.S. FDA
The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.
Lupin gets USFDA nod for multiple sclerosis drug
Lupin receives USFDA approval for generic Siponimod Tablets to treat multiple sclerosis, boosting market presence and potential sales.
South Korea to require advertisers to label AI-generated ads
South Korea will require advertisers to label their ads made with artificial intelligence technologies from next year as it seeks to curb a surge of deceptive promotions ...
Miracle Cure or Toxic Myth? New Research Exposes the Truth About MMS
A “miracle cure” meets real science — and the results are alarming. Miracle Mineral Solution, or MMS, has long been promoted as a supposed cure for a wide range of illnesses, from cancer and autism to ...